| Joshua Clark, MD | |
|
1605 G St, Springfield, OR 97477-4227 | |
| (541) 747-6159 | |
| (458) 201-8510 |
| Full Name | Joshua Clark |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 8 Years |
| Location | 1605 G St, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710349592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD197684 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joshua J Clark Md Llc | 7618354432 | 2 |
News Archive
TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.
Colleges are saying the new health law could keep them from offering low-cost, limited benefit student health insurance plans, "and they're seeking federal authority to continue offering them," Kaiser Health News reports. "Without a number of changes, it may be impossible 'to continue to offer student health plans,' says an Aug. 12 letter sent to Health and Human Services Secretary Kathleen Sebelius from the American Council on Education and signed by 12 other trade associations representing colleges."
Australian scientists are on the brink of a discovery that could change treatment of patients with Parkinson's disease (PD). Transplanting stem cells could be the next big thing in PD therapy they claim.
Researchers Lorenzo Pasquali and Mireia Ramos-Rodríguez have published recently in Nature Genetics the results of a study on the mechanisms that cause an inflammatory response to trigger pancreatic beta-cell death, leading to the onset of Type 1 Diabetes (T1D).
› Verified 1 days ago
| Entity Name | Troy Richey Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467559286 PECOS PAC ID: 8123193471 Enrollment ID: O20080820000681 |
News Archive
TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.
Colleges are saying the new health law could keep them from offering low-cost, limited benefit student health insurance plans, "and they're seeking federal authority to continue offering them," Kaiser Health News reports. "Without a number of changes, it may be impossible 'to continue to offer student health plans,' says an Aug. 12 letter sent to Health and Human Services Secretary Kathleen Sebelius from the American Council on Education and signed by 12 other trade associations representing colleges."
Australian scientists are on the brink of a discovery that could change treatment of patients with Parkinson's disease (PD). Transplanting stem cells could be the next big thing in PD therapy they claim.
Researchers Lorenzo Pasquali and Mireia Ramos-Rodríguez have published recently in Nature Genetics the results of a study on the mechanisms that cause an inflammatory response to trigger pancreatic beta-cell death, leading to the onset of Type 1 Diabetes (T1D).
› Verified 1 days ago
| Entity Name | Joshua J Clark Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346994811 PECOS PAC ID: 7618354432 Enrollment ID: O20220517002988 |
News Archive
TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.
Colleges are saying the new health law could keep them from offering low-cost, limited benefit student health insurance plans, "and they're seeking federal authority to continue offering them," Kaiser Health News reports. "Without a number of changes, it may be impossible 'to continue to offer student health plans,' says an Aug. 12 letter sent to Health and Human Services Secretary Kathleen Sebelius from the American Council on Education and signed by 12 other trade associations representing colleges."
Australian scientists are on the brink of a discovery that could change treatment of patients with Parkinson's disease (PD). Transplanting stem cells could be the next big thing in PD therapy they claim.
Researchers Lorenzo Pasquali and Mireia Ramos-Rodríguez have published recently in Nature Genetics the results of a study on the mechanisms that cause an inflammatory response to trigger pancreatic beta-cell death, leading to the onset of Type 1 Diabetes (T1D).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Clark, MD 360 S Garden Way, Ste 230, Eugene, OR 97401-8187 Ph: (541) 747-6159 | Joshua Clark, MD 1605 G St, Springfield, OR 97477-4227 Ph: (541) 747-6159 |
News Archive
TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.
Colleges are saying the new health law could keep them from offering low-cost, limited benefit student health insurance plans, "and they're seeking federal authority to continue offering them," Kaiser Health News reports. "Without a number of changes, it may be impossible 'to continue to offer student health plans,' says an Aug. 12 letter sent to Health and Human Services Secretary Kathleen Sebelius from the American Council on Education and signed by 12 other trade associations representing colleges."
Australian scientists are on the brink of a discovery that could change treatment of patients with Parkinson's disease (PD). Transplanting stem cells could be the next big thing in PD therapy they claim.
Researchers Lorenzo Pasquali and Mireia Ramos-Rodríguez have published recently in Nature Genetics the results of a study on the mechanisms that cause an inflammatory response to trigger pancreatic beta-cell death, leading to the onset of Type 1 Diabetes (T1D).
› Verified 1 days ago
Dr. Natalie Elizabeth Kudlak, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1007 Harlow Rd Ste 310, Springfield, OR 97477 Phone: 541-242-4300 | |
Lindsey Fix, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21 Hayden Bridge Way, Springfield, OR 97477 Phone: 541-600-2017 Fax: 541-225-4864 |